Recent Finacing
Recent Raise
PellePharm develops topical patidegib gel, a hedgehog-pathway inhibitor for Gorlin Syndrome and basal cell carcinoma, advancing from positive Phase 2 results into a Phase 3 and LEO Pharma collaboration.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at PellePharm.
